Influenza Vaccine Market

Excell Reports has released its latest research-based report entitled “Global Influenza Vaccine MarketMarket. As of 2017, the Influenza Vaccine market size was valued at USD 4.52 billion and is projected to grow at a CAGR of 12.0%. As the world moves towards an aging population, people’s susceptibility to influenza increases, raising demand for flu vaccines. Also improving healthcare systems, growing flu awareness and high birth rates in developing countries will fuel demand for existing and new influenza vaccines from 2017. The influenza vaccination industry thus holds great potential for progress and high sales.

Influenza vaccine market is expected to flourish rapidly in the near future. The key factor attributing to the market growth is the need for development of new version of influenza vaccine owing to the frequently changing influenza virus. Moreover, escalating demand of pediatrics influenza vaccines as well as high demand from emerging markets is also expected to fuel market growth during the forecast period.

Download Sample research report with tables and figures @

The influenza vaccines market is majorly dominated by only 4 major pharmaceutical companies dominating the industry: Sanofi Pasteur, Seqirus, GSK and AstraZeneca. Sanofi held the largest share in the market with its bestselling influenza vaccine, Vaxigrip/Fluzone HD/Fluzone. It accounted for maximum share in 2017 and is anticipated to maintain its dominance throughout the forecast period. In influenza vaccine market by type segmentation quadrivalent vaccine accounted the major market share in 2017

Segments covered in the report –
• Global Influenza Vaccine Market by Type (USD Million, 2016-2025)
o Quadrivalent
o Trivalent
• Global Influenza Vaccine Market By Product (USD Million, 2016-2025)
o Vaxigrip/Fluzone HD/Fluzone
o Afluria/Fluvirin/Fluad/Flucelvax/Aggripal
o Fluarix/FluLaval
o FluMist/Fluenz
o Others

• Global Influenza Vaccine Market by Region (USD Million, 2016-2025)
o US
o Germany
o UK
o France
o Italy
o Spain
o China
o India
o Japan
o Brazil
o Russia
o RoW

Ask For Discount @

Table Of Contents:

  1. 1 Market Introduction
    1 Introduction 
    1.2 Scope of Study 
         1.2.1 Research Objective 
    1.3 Currency & Pricing 
    1.4 Limitations 
    1.5 Assumptions
  2. 2 Executive Summary
    1 Global Influenza Vaccine Market Projection, 2018 – 2025 
    2.2 Global Influenza Vaccine Market CAGR Growth, By Regions
  3. 3 Research Methodology
    1 Introduction 
    3.2 Primary Research 
    3.3 Secondary Research 
    3.4 Market Size Estimation 
         3.4.1 Bottom-up Approach 
         3.4.2 Top-down Approach 
         3.4.3 Market Breakdown and Data Triangulation
  4. 4 Market Dynamics
    1 Drivers 
    4.2 Restraints 
    4.3 PEST Analysis 
         4.3.1 Political 
         4.3.2 Economic 
         4.3.3 Social 
         4.3.4 Technological 
    4.4 Porters Five Forces Analysis 
    4.5 SWOT Analysis 
         4.5.1 Strengths 
         4.5.2 Weaknesses

            4.5.3 Opportunities 
            4.5.4 Threats 

    5 Global Influenza Vaccine Market, By Product

  1. 1 Product Overview 
         5.1.1 Fluzone/Vaxigrip 
         5.1.2 Afluria/Fluvirin/Fluad/Flucelvax/Aggripal 
         5.1.3 Fluarix/FluLaval 
         5.1.4 FluMist/Fluenz 
         5.1.5 Other Influenza Vaccines 
  2. 6 Global Influenza Vaccine Market, By Type
    1 Type Overview 
    6.1.1 Quadrivalent Influenza Vaccines 
    6.1.2 Trivalent Influenza Vaccines 
  3. 7 Global Influenza Vaccine Market, By Region
  4. 8 Company Profiles 
    1 Sanofi Pasteur Inc.

8.1.1 Company/Business Overview 
            8.1.2 Financial Overview 
            8.1.3 Product Bench marking 
            8.1.4 Product Pipeline 
            8.1.5 Key Developments 

8.2 GlaxoSmithKline 
            8.2.1 Company/Business Overview 
            8.2.2 Financial Overview 
            8.2.3 Product Bench marking 
            8.2.4 Product Pipeline 
            8.2.5 Key Development 

8.3 Seqirus 
            8.3.1 Company/ Business Overview 
            8.3.2 Financial Overview 
            8.3.3 Product Bench marking 
            8.3.4 Product Pipeline 
            8.3.5 Key Development 

8.4 AstraZeneca 
            8.4.1 Company/ Business Overview 
            8.4.2 Financial Overview 
            8.4.3 Product Bench marking 
            8.4.4 Key Development 
            8.5 Serum Institute of India Pvt. Ltd. 
            8.5.1 Company/ Business Overview 
            8.5.2 Product Bench marking 

8.6 Abbott 
            8.6.1 Company/ Business Overview 
            8.6.2 Financial Overview 
            8.6.3 Product Bench marking 

About Us:

Excell reports is one of the leading distributors of Market Intelligence reports produced by premium publishers. Being a one stop solution for research requirements, our Market Intelligence reports help our clients to keep abreast of thousands of industries all-round the globe. A better understanding of the predicted market conditions, a clear picture of supply and source industries allows our clients to closely monitor competitor activities. Our large database of more than 50,000 quality driven reports from over 40+ leading publisher ensures that your market research requirements are sufficed.

Contact Us:

Mr. Ravi B.

Excell Reports

9701 Wilshire Boulevard 10th Floor

Beverly Hills, 

California 90212

Tel – +18448939235 

Email :

WebSite :



Please enter your comment!
Please enter your name here

three × 3 =